Brain MR perfusion imaging in humans: Advantages of high-molarity gadolinium chelates

Acta Radiologica

Volumn 42, Issue 6, 2001, Pages 555-559

  Griffiths, Paul D ^a,c   Wilkinson, I D ^a   Wels, T ^b   Hoggard, N ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b BAYER PHARMA AG   (Germany)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Brain perfusion, MR; Contrast medium, gadolinium

Indexed keywords

CHELATING AGENT; DIAGNOSTIC AGENT; GADOLINIUM;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN ARACHNOID CYST; BRAIN CIRCULATION; CLINICAL TRIAL; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; SCLEROSIS; SEIZURE; TEMPORAL LOBE;

ADOLESCENT; ADULT; ARACHNOID CYSTS; AREA UNDER CURVE; CEREBROVASCULAR CIRCULATION; CHELATING AGENTS; ECHO-PLANAR IMAGING; FEMALE; GADOLINIUM; HUMAN; MALE; MIDDLE AGE; PERFUSION; SCLEROSIS; SEIZURES; SUPPORT, NON-U.S. GOV'T; TEMPORAL LOBE;

EID: 0035510563     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418501127347368     Document Type: Article

References (5)

1. BENNER T., REIMER P., ERB G. et al.: Cerebral MR perfusion imaging. First clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J. Magn. Reson. Imaging 12 (2000), 371.
2. BRADLEY W. G. JR: Optimizing lesion contrast without using contrast agents. Magn. Reson. Imaging 10 (1999), 442.
3. EDELMAN R. R., MATTLE H. P., ATKINSON D. J. et al.: Cerebral blood flow. Assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 176 (1990), 211.
4. PLEWES D. B. & DEAN P. B.: Detectability of spherical objects by computed tomography. Radiology 133 (1979), 785.
5. TONG D. C., YENARI M. A., ALBERS G. W., O-BRIEN M., MARKS M. P. & MOSELEY M. E.: Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 50 (1998), 864.